Zepbound : $1,050+/month for pre-filled pens or $349$500/month for single-dose vials, depending on dosage and insurance
Lock Drops: Aqua/Water/Eau, Aloe Barbadensis Leaf Juice*, Propanediol, Glycerin, Polysorbate 20, Butylene Glycol, Hydroxyacetophenone, Caprylyl Glycol, Pentylene Glycol, Sodium Benzoate, Panthenol, Potassium Sorbate, Parfum/Fragrance, Lecithin, Sodium Phytate, Ethylhexylglycerin, Benzyl Benzoate, PPG-26-Buteth-26, PEG-40 Hydrogenated Castor Oil, Hexamethylindanopyran, Glycine, Larix Europaea Wood Extract, Citric Acid, Sodium Metabisulfite, 1,2-Hexanediol, Acetyl Glutamine, Chamomilla Recutita (Matricaria) Flower Extract*, Equisetum Arvense Extract, Hibiscus Sabdariffa Flower Extract, Hylocereus Undatus Fruit Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract*, SH-Oligopeptide-1, SH-Oligopeptide-2, SH-Polypeptide-1, SH-Polypeptide-11, SH-Polypeptide-9, Sodium Hyaluronate, Urtica Dioica (Nettle) Leaf Extract, Bacillus/Folic Acid Ferment Filtrate Extract, Limonene, Alpha-Isomethyl Ionone, Camellia Sinensis Leaf Extract, Zinc Chloride, Apigenin, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Mentha Arvensis Leaf Oil*, Oleanolic Acid, Biotinoyl Tripeptide-1, Hexyl Cinnamal, Linalyl Acetate, Benzyl Alcohol
Unlike natural GLP-1, which has a very short lifespan in the body, GLP-1 agonists are designed to resist degradation by DPP-4, giving them a longer half-life
Research-Grade Retatrutide vs Compounded or Clinical-Trial Supply Retatrutide is the proprietary investigational compound of Eli Lilly and Company
and has received consultancy fees from AstraZeneca, Boehringer Ingelheim, Lilly USA, Merck & Co., Inc., Pfizer, Novo Nordisk, Metavant, Afimmune, and Sanofi
